Mei, Davide Antonio
 Distribuzione geografica
Continente #
AS - Asia 2.105
NA - Nord America 1.183
EU - Europa 865
SA - Sud America 350
AF - Africa 26
OC - Oceania 6
Totale 4.535
Nazione #
US - Stati Uniti d'America 1.131
CN - Cina 847
SG - Singapore 613
IT - Italia 350
BR - Brasile 276
HK - Hong Kong 236
VN - Vietnam 158
GB - Regno Unito 116
KR - Corea 99
RU - Federazione Russa 91
DE - Germania 85
FI - Finlandia 48
ID - Indonesia 45
AR - Argentina 43
FR - Francia 31
NL - Olanda 27
MX - Messico 23
SE - Svezia 23
CA - Canada 19
PL - Polonia 16
AT - Austria 15
ES - Italia 15
IN - India 15
TR - Turchia 13
LT - Lituania 10
ZA - Sudafrica 10
IQ - Iraq 9
TW - Taiwan 9
BD - Bangladesh 8
BE - Belgio 8
EC - Ecuador 8
UA - Ucraina 8
UZ - Uzbekistan 8
AU - Australia 6
JP - Giappone 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CU - Cuba 5
EG - Egitto 5
PK - Pakistan 5
BG - Bulgaria 4
GE - Georgia 4
IL - Israele 4
KE - Kenya 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
HU - Ungheria 3
KZ - Kazakistan 3
PE - Perù 3
PT - Portogallo 3
SA - Arabia Saudita 3
CL - Cile 2
IE - Irlanda 2
JO - Giordania 2
MA - Marocco 2
PA - Panama 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 4.535
Città #
Hefei 499
Singapore 378
Santa Clara 317
Hong Kong 236
Ashburn 210
Seoul 99
Beijing 86
London 74
New York 54
Ho Chi Minh City 50
Chicago 45
Munich 42
Los Angeles 40
Bologna 39
Hanoi 39
Milan 39
Jakarta 35
São Paulo 31
Dallas 29
Kent 29
Moscow 29
Buffalo 25
Lappeenranta 22
Rome 22
Shanghai 21
Mexico City 15
Portsmouth 15
Salt Lake City 14
Amsterdam 13
Chandler 13
Helsinki 13
Modena 13
Nyköping 13
Turku 13
Nuremberg 12
The Dalles 12
Fairfield 11
Lauterbourg 11
Warsaw 11
Düsseldorf 10
Boardman 9
Curitiba 9
Orem 9
Atlanta 8
Campinas 8
Da Nang 8
Elk Grove Village 8
Stockholm 8
Turin 8
Brussels 7
Carpi 7
Redondo Beach 7
Rio de Janeiro 7
Tampa 7
Tashkent 7
Vienna 7
Bari 6
Brescia 6
Brooklyn 6
Frankfurt am Main 6
Haiphong 6
Hangzhou 6
Miami 6
Montreal 6
Paris 6
Reggio Emilia 6
Salvador 6
Tokyo 6
Vigasio 6
Belo Horizonte 5
Biên Hòa 5
Columbus 5
Council Bluffs 5
Fortaleza 5
Harbin 5
Havana 5
Naples 5
Parma 5
Perugia 5
Phoenix 5
San Sebastiano al Vesuvio 5
Scicli 5
Seattle 5
Bắc Ninh 4
Chennai 4
Fiorenzuola d'Arda 4
Formigine 4
Houston 4
Istanbul 4
Johannesburg 4
La Plata 4
Macerata 4
Madrid 4
Manchester 4
Mumbai 4
Pontassieve 4
Porto Alegre 4
Recife 4
Sala Baganza 4
San Diego 4
Totale 3.019
Nome #
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 215
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 174
Remote monitoring and telemedicine in heart failure: implementation and benefits 173
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 162
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 136
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 133
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 133
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 129
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 121
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 121
Single-lead VDD pacing: a literature review on short-term and long-term performance 119
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 117
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 114
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 112
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 111
Clinical decisions for appropriate management of patients with atrial fibrillation 110
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 109
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 109
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 104
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 97
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry 95
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 95
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 93
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 88
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 86
Antiarrhythmic drugs in the era of atrial fibrillation ablation 85
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 84
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 78
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry 78
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 77
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: An analysis from the GLORIA-AF registry 76
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 75
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 72
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 68
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 68
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 67
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 63
Atrial fibrillation screening: The importance of the patient perspective 62
Prepare our healthcare systems to manage complexity: the case of atrial fibrillation 58
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 53
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry 51
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future? 42
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 38
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 36
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time? 32
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 24
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 20
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? 20
Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease 20
Antiarrhythmic drugs and ablation in patients with atrial fibrillation: New perspectives 20
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III 19
A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium 18
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial 18
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial 16
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry 16
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project 16
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort 15
Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry 14
Atrial fibrillation ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term 14
Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey? 12
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation 12
The intriguing relationships between atrial fibrillation and heart failure: insights from cardiac implantable electronic devices 7
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 5
Totale 4.605
Categoria #
all - tutte 22.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 13 2 1 0 2 6 0 0 1 3 6 10
2022/2023110 7 6 8 7 5 5 4 12 15 6 27 8
2023/2024427 5 18 26 52 109 47 39 44 9 15 20 43
2024/20251.783 24 12 17 76 205 282 168 139 186 131 292 251
2025/20262.241 342 233 378 662 600 26 0 0 0 0 0 0
Totale 4.605